Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
Become a Member | Sign in
Home>News>This Article

New ‘Supermix’ Controls Totally Streamline QC in Medical Laboratories

Published: Tuesday, October 15, 2013
Last Updated: Tuesday, October 15, 2013
Bookmark and Share
Randox has launched two new liquid assayed chemistry controls, which save time and money whilst ensuring highly accurate results and patient diagnosis.

The new controls, Acusera Liquid Assayed Chemistry Premium and Premium Plus, are designed to drastically cut the number of individual quality controls (QC) a laboratory needs to run in routine medical testing. Using the Randox controls laboratories can run QC on up to 100 analytes all within one test, without compromising performance or accuracy.  

The concept of offering multi-analyte controls is not new. However, these latest assayed controls from Randox are the most comprehensive on the world market to date, containing a unique combination of proteins, lipids, immunoassays, cardiac markers, blood markers, therapeutic drugs and routine chemistry analytes. 

The Acusera Chemistry Premium Plus control contains 100 analytes, whilst the Acusera Chemistry Premium control offers 91, with the following features:

• The high levels of CRP and other key proteins included eliminate the need for multiple controls, dramatically streamlining QC in laboratories.
• They are assayed controls, providing clinically significant values for a wide range of analysers at key decision points.
• Both controls are liquid for ease of use, eliminating possible reconstitution errors and improving lab efficiency.
• Available in 3 concentration levels (low, mid and high), Premium Plus covers the full clinical range, removing the need for laboratories to purchase additional, and often expensive, low or high level controls.
• The controls are highly stable when stored at -20 to -70°C with open vial stability of up to 7 days at +2-8°c, reducing wastage in laboratories.
• They are manufactured using human-based serum, ensuring performance that closely mirrors patient samples.
• As true third party controls, laboratories are assured of truly unbiased, independent assessment of analytical performance and as such help deliver highly accurate results and patient diagnosis.

The controls are now available in the UK, Europe, Middle East, Far East and Africa. Randox is currently awaiting product approval from the US FDA and China SFDA.

‘These new assayed controls will be hugely beneficial to medical laboratories running a wide range of routine patient tests, allowing them to consolidate all or the majority of their QC within one control. ’ said Dr John Campbell, BSc, PhD

Steven Jordan, Randox’s Global Manager for QC, commented, ‘Randox reputation as a leading global provider of quality controls takes another step forward with the launch of Acusera Liquid Chemistry Premium and Premium Plus. We’re delighted to be pushing the boundaries of quality control, helping laboratories improve their performance and productivity whilst ensuring highly accurate results and improving patient diagnosis.’

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Randox Wins NI Hospital Trusts Business
Randox fought off global competition to win a five year contract to supply quality control products to the Northern Ireland Health & Social Care Trusts.
Monday, December 09, 2013
UK Trade and Investment Joins Hands with Randox
UK Trade and Investment organize healthcare seminars in Pakistan on “Improving Healthcare and Laboratory performance in Pakistan.”
Thursday, May 30, 2013
Newly Launched RIQAS Website Makes EQA Even Simpler for Laboratories Worldwide allows users to easily discover the many benefits offered by the world’s largest External Quality Assessment (EQA) scheme, Randox International Quality Assessment Scheme (RIQAS) and the advantages of implementing EQA in their laboratory.
Monday, March 04, 2013
You Don’t have to be a Scientist to Work in Healthcare
Randox is expanding its workforce with the recent recruitment of 42 individuals throughout October and November.
Thursday, November 15, 2012
Randox Opens New Manufacturing Facility in Bangalore, India
New Bangalore manufacturing facility to enhance product quality, ensure on time delivery and generate excellent customer satisfaction.
Friday, April 27, 2012
Scientific News
Mathematical Model Forecasts the Path of Breast Cancer
Chances of survival depend on which organs breast cancer tumors colonize first.
Measuring microRNAs in Blood to Speed Cancer Detection
A simple, ultrasensitive microRNA sensor holds promise for the design of new diagnostic strategies and, potentially, for the prognosis and treatment of pancreatic and other cancers.
Biomedical Imaging at One-Thousandth the Cost
Mathematical modeling enables $100 depth sensor to approximate the measurements of a $100,000 piece of lab equipment.
Improving Outcomes for Lung Cancer and Diabetic Patients
Novel technologies have been developed with support from SBRI Healthcare funding.
New Way of Detecting Cancer
A new RNA test of blood platelets can be used to detect, classify and pinpoint the location of cancer by analysing a sample equivalent to one drop of blood.
Rapid, Portable Ebola Diagnostic
Scientists confirmed the efficiency of the novel Ebola detection method in field trials.
New, Better Test for Prostate Cancer
A study from Karolinska Institutet shows that a new test for prostate cancer is better at detecting aggressive cancer than PSA.
Blood Test Picks Out Prostate Cancer Drug Resistance
Scientists have developed a blood test that can identify key mutations driving resistance to a widely used prostate cancer drug, and identify in advance patients who will not respond to treatment.
Antibody Targets Key Cancer Marker
University of Wisconsin-Madison researchers have created a molecular structure that attaches to a molecule on highly aggressive brain cancer and causes tumors to light up in a scanning machine.
Key Piece of MRSA Vaccine Puzzle
New research funded by the Health Research Board and the Wellcome Trust has pinpointed immune cells that could be targeted by an MRSA vaccine.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos